Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ehealth ( (EHTH) ) has issued an update.
On September 17, 2025, Aaron Tolson resigned from the Board of Directors of eHealth, Inc., along with its various committees, and was replaced by Todd Arden, a designee of Echelon Health SPV, LP, under the terms of an existing Investment Agreement. Additionally, Derrick Duke was appointed as a new director, increasing the total number of directors from nine to ten. Both appointments are effective immediately and will last until the 2028 annual meeting of stockholders. These changes are part of the company’s ongoing governance adjustments, with no disagreements or undisclosed relationships involved.
The most recent analyst rating on (EHTH) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.
Spark’s Take on EHTH Stock
According to Spark, TipRanks’ AI Analyst, EHTH is a Neutral.
Ehealth’s overall stock score reflects a balance of improved profitability and strategic advancements against significant challenges in revenue growth, cash flow, and valuation. The positive earnings call guidance and AI initiatives provide some optimism, but financial and regulatory hurdles remain.
To see Spark’s full report on EHTH stock, click here.
More about Ehealth
Average Trading Volume: 485,785
Technical Sentiment Signal: Sell
Current Market Cap: $117.6M
For an in-depth examination of EHTH stock, go to TipRanks’ Overview page.